Media & Investors
Get the latest news and discover our mission and vision. Meet our company speakers and get in touch for press and investor inquiries.
Get the latest news and discover our mission and vision. Meet our company speakers and get in touch for press and investor inquiries.
Read the latest of myTomorrows
December 6, 2023
CEO Michel van Harten speaks with Clinical Trial Vanguard about myTomorrows’ innovative use of AI in physician-led clinical trial screening.
September 13, 2023
myTomorrows teams up with digital health innovator Congenica, highlighting tech’s role in the future of healthcare.
April 27, 2023
Fierce Biotech shares launch of myTomorrows exciting new AI-backed patient pre-screening tool.
June 28, 2023
myTomorrows’ CEO explores the power of AI for matching patients with the clinical trials right for them
November 29, 2023
"I started myTomorrows in 2012 after losing my father to an aggressive form of lung cancer. As a physician and founder of several biotech companies, I thought I could help him find and access a treatment in development. But I was surprised at how complicated and slow the process was. I decided this had to change, so I dedicated myself to creating an easier and faster way for patients to access treatments in development.
We have grown a lot since then, and our team of experts has helped patients in over 60 countries. But our guiding principle remains the same: We believe every patient should have access to all possible treatment options. We are here for you, so let us know how we can help."
Our experts have been pulled in to discuss a wide range of topics, from patient-centricity, clinical trials, expanded access, innovation, healthcare technology, artificial intelligence, and many more. Get in touch with them.
myTomorrows aims to break barriers for eligible patients seeking information about clinical trials and we support referrals to trial sites. When patients are not eligible to clinical studies, we can help them and their physicians to further explore and navigate the complexities of expanded access programs.
Our digital platform connects all stakeholders in pre-approval access and supports both clinical trial and expanded access workflows.
myTomorrows operates globally and has offices in Amsterdam and New York City.
We’ve helped
A community of
Trusted by
Media inquiries
mytomorrows@headline.media
